nach oben

Erschienen in:

01.09.2012 | Short Communication

Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population

verfasst von: Lisbeth Herrera-Romano, Nora Fernández-Tamayo, Eduardo Gómez-Conde, Juan M. Reyes-Cardoso, Felipe Ortiz-Gutierrez, Guillermo Ceballos, Alejandra Valdivia, Patricia Piña, Mauricio Salcedo

Erschienen in: Medical Oncology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The role of human papillomavirus (HPV) in breast cancer is controversial. We evaluated 118 breast carcinomas and two paraffin-embedded tissues of lesions of the nipple of Mexican patients for HPV sequences. No carcinoma sample exhibited koilocytosis, in contrast to lesions of the nipple. We subjected purified DNAs to PCR employing two HPV16/E6 or GP5/6 primer set oligonucleotides. Results showed that HPV DNA sequences were absent in the breast tissues. Absence of HPV in breast carcinoma failed to support an association between HPV infection and this carcinoma.

Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol. 2009;33:315–8.PubMedCrossRef

Rodríguez-Cuevas S, Guisa-Hohenstein F, Labastida-Almendaro S. First breast cancer mammography screening program in Mexico: initial results 2005–2006. Breast J. 2009;15:623–31.PubMedCrossRef

Akil N, Yasmeen A, Kassab A, Ghabreau L, Darnel AD, Al Moustafa AE. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer. 2008;99:404–7.PubMedCrossRef

Choi YL, Cho EY, Kim JH, Nam SJ, Oh YL, Song SY, Yang JH, Kim DS. Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol. 2007;28:327–32.PubMedCrossRef

Damin A, Karam R, Zettler CG, Caleffi M, Alexandre CO. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat. 2004;84:131–7.PubMedCrossRef

de Villiers E-M, Sandstrom RE, zur Hausen H, Buck CE. Presence of papillomatous sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res. 2005;7:R1–11.PubMedCrossRef

Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS. HPV DNA frequency and subset analysis in human breast cancer patients’ normal and tumoral tissue samples. J Exp Clin Cancer Res. 2006;25:515–21.PubMed

Hennig EM, Suo Z, Thoresen S, Holm R, Kvinnsland S, Nesland JM. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat. 1999;53:121–35.PubMedCrossRef

Kan CY, Iacopetta BJ, Lawson JS, Whitaker J. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer. 2005;93:946–8.PubMedCrossRef

10.

Khan NA, Castillo A, Koriyama C, Kijima Y, Umekita Y, Ohi Y, Higashi M, Sagara Y, Yoshinaka H, Tsuji T, Natsugoe S, Douchi T, Eizuru Y, Akiba S. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer. 2008;99:408–14.PubMedCrossRef

11.

Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem. 2006;39:727–31.PubMedCrossRef

12.

Liu Y, Klimberg VS, Andrews NR, Hicks CR, Peng H, Chiriva-Internati M, Henry-Tillman R, Hermonat PL. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol. 2001;4:329–34.PubMed

13.

Di Lonardo DA, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat. 1992;21:95–100.PubMedCrossRef

14.

Mendizábal-Ruiz AP, Morales JA, Ramírez-Jirano LJ, Padilla-Rosas M, Morán-Moguel MC, Montoya-Fuentes H. Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat. 2009;114:189–94.PubMedCrossRef

15.

Heng B, Glenn WK, Ye Y, Tran B, Delprado W, Lutze-Mann L, Whitaker NJ, Lawson JS. Human papilloma virus is associated with breast cancer. Br J Cancer. 2009;101:1345–50.PubMedCrossRef

16.

Ong K, Koay ES, Putti TC. Detection of cutaneous HPV types 4 and 24 DNA sequences in breast carcinoma in Singaporean women of Asian ancestry. Pathology. 2009;41:436–42.PubMedCrossRef

17.

de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2008;109:55–8.PubMedCrossRef

18.

de León DC, Montiel DP, Nemcova J, Mykyskova I, Turcios E, Villavicencio V, et al. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients. BMC Cancer. 2009;22:9–21.

19.

Cazzaniga M, Gheit T, Casadio C, Khan N, Macis D, Valenti F, et al. Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis. Breast Cancer Treat Res. 2009;114:599–605.CrossRef

20.

Lindel K, Forster A, Altermatt HJ, Greiner R, Gruber G. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast. 2007;16:172–7.PubMedCrossRef

21.

Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol. 2005;75:276–81.PubMedCrossRef

22.

Yu Y, Morimoto T, Sasa M, Okazaki K, Harada Y, Fujiwara T, et al. HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res. 1999;19:5057–61.PubMed

23.

Gopalkrishna V, Singh UR, Sodhani P, Sharma JK, Hedau ST, et al. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat. 1996;39:197–202.PubMedCrossRef

24.

Bratthauer GL, Tavassoli FA, O’Leary TJ. Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract. 1992;188:384–6.PubMedCrossRef

25.

Wrede D, Luqmani YA, Coombes RC, Vousden KH. Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer. 1992;65:891–4.PubMedCrossRef

26.

Manavi M, Baghestanian M, Kucera E, Berger A, Schatten C, Pischinger K, Czerwenka K. Papilloma virus and c-erbB-2 expression in diseases of the mammary nipple. Anticancer Res. 2001;21:797–801.PubMed

27.

Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol. 2004;31:292–7.PubMedCrossRef

28.

de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 39 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995;76:1057–62.PubMedCrossRef

29.

Terris M, Peehl DM. Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology. 1997;50:150–6.PubMedCrossRef

30.

Obiso R, Lorincz A. Digene Corporation. Pharmacogenomics. 2004;5:129–32.PubMedCrossRef

31.

Cardiff RD, Kenney N. Mouse mammary tumor biology: a short history. Adv Cancer Res. 2007;98:53–116.PubMedCrossRef

32.

Chang P, Wang T, Yao Q, Lv Y, et al. Absence of human papillomavirus in patients with breast cancer in north-west China. Med Oncol. 2011 (in press).

33.

Aguayo F, Kahn N, Koriyama C, González C, Ampuero S, et al. Human papillomavirus and Epstein Barr virus infections in breast cancer from Chile. Infect Agent Cancer. 2011;23; 6(1):7.CrossRef

34.

Hedau S, Kumar U, Hussain S, Shukla S, Pande S, et al. Breast cancer and human papillomavirus infection: no evidence of HPV etiology of breast cancer in Indian women. BMC Cancer. 2011;20; 11:27.CrossRef

Titel: Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population
verfasst von: Lisbeth Herrera-Romano
Nora Fernández-Tamayo
Eduardo Gómez-Conde
Juan M. Reyes-Cardoso
Felipe Ortiz-Gutierrez
Guillermo Ceballos
Alejandra Valdivia
Patricia Piña
Mauricio Salcedo
Publikationsdatum: 01.09.2012
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 3/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-011-0059-x

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Leptomeningeal carcinomatosis from ovarian cancer

Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17)

Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission

A novel prognostic model for extranodal natural killer/T-cell lymphoma

Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer

Long-term chemotherapy may prolong survival in advanced non-small-cell lung cancer among responders to first-line chemotherapy

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie